Universities across the country are part of the urgent effort to research the virus SARS-CoV-2 and the disease it causes, COVID-19, together colloquially called the coronavirus. Globally, the virus has infected over 90,000 people and resulted in over 3,000 deaths, including nine in the United States.
After receiving approval from the Centers for Disease Control and Prevention, researchers at the University of Pittsburgh have received vials of the virus for study. The Center for Vaccine Research at the university, where Dr. Jonas Salk developed the polio vaccine, will be working on a potential vaccine candidate.
